Although several major immunologic hurdles need to be overcome, the pig is
currently considered the most likely source animal of cells, tissues and or
gans for transplantation into humans. Concerns have been raised with regard
to the potential for the transfer of infectious agents with the transplant
ed organ to the human recipient. This risk is perceived to be increased as
it is likely that the patient will be iatrogenically immunocompromised and
the organ-source pig may be genetically engineered in such a way to render
its organs particularly susceptible to infection with human viruses. Furthe
rmore, the risk may not be restricted to the recipient, but may have conseq
uences for the health of others in the community, The identification of por
cine endogenous retroviruses and of hitherto unknown viruses have given ris
e to the most concern, We document here the agents we believe should be exc
luded from the organ-source pigs. We discuss the likelihood of achieving th
is aim and outline the potential means by which it may best be achieved.